Coronavirus India updates

  • ‘India at forefront of research for Covid-19 vaccine’, says PM Modi at US-India summit: India, a country with 1.3 billion people and limited resources, has one of the lowest death rates per million in the world. The recovery rate is also steadily rising,” said PM Modi at the summit….read more
  • Recovered COVID-19 patients facing difficulties: After acute COVID-19 illness, recovered patients may continue to report a wide variety of signs and symptoms, including fatigue, body ache, cough, sore throat, difficulty in breathing, etc….read more
  • Front-line workers will get vaccine first: Harsh Vardhan: “I shall be the first to offer myself for receiving COVID-19 vaccine if people have a trust deficit,” said Union Health Minister Harsh Vardhan while interacting on the Sunday Samvad social media platform…..read more
  • Self-check kiosk to detect, prevent Covid-19: With the gradual easing of public lockdown measures and return to normal life, it is the need of the hour to ensure safe entry to any premises. Indian Institute of Technology Guwahati (IIT Guwahati) in collaboration with Workspace Metal Solutions Private Limited, Udaipur, has developed a first-of-its-kind self-check kiosk. The small structure helps by streamlining flow of people through the kiosk. The Kiosk only takes about 30 seconds to check whether the person is safe to enter the premises or not….read more
  • India’s COVID-19 record ‘less flattering’: US research paper: The working paper, published by the US-based National Bureau of Economic Research argues that India’s low COVID-19 relative to the world average and other countries of high virus infection is because of its relatively young population, and not resistance to the disease. India’s case fatality rate (CFR) under COVID-19 is around 2.2 per cent as against world average of around 4 per cent…..read more
  • Tracking global genetic variability, predicting viral  sequences to  resolve  COVID  19 challenge: A group of scientists in India is working on genomic sequences of SARS-CoV-2 around the World, including India, to identify genetic variability and potential molecular targets in virus and human to find the best possible answer to combat the COVID 19 virus. The study being sponsored by Science and Engineering Research Board (SERB),a statutory body under the Department of Science and Technology (DST), has been published in the Journal called Infection, Genetics, and Evolution. They have mainly found 57 out of 64 SNPs are present in 6 coding regions of Indian SARS-CoV-2 genomes, and all are nonsynonymous in nature….read more
  • Neurons in the nose & hypothalamus may be entry points of SARS-CoV-2 virus to brain: Dr. Vincent Prevot, previously a principal investigator supported by the Indo-French Centre for the Promotion of Advanced Research (CEFIPRA),supported by the Department of Science &Technology, Govt. of India along with a team of Indian and French scientists, have shown that specialized glial cell called tanycytes in the hypothalamus, as well as olfactory neurons, could provide an opening for SARS-CoV-2 into the brain. They have also shown that hypothalamic circuits could act as a hub for the numerous risk factors as well as the physiological effects of viral infection. This work has been published in the journal ‘bioRxiv’….read more